Spots Global Cancer Trial Database for camptosar
Every month we try and update this database with for camptosar cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) | NCT00735436 | Malignant Gliom... Glioblastoma Mu... Gliosarcoma | Gliadel/Avastin... | 18 Years - | Duke University | |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | NCT00036517 | Colorectal Neop... Diarrhea | PHY906 | 18 Years - 75 Years | PhytoCeutica | |
| A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases | NCT01939483 | Central Nervous... Male Breast Can... Recurrent Breas... Stage IV Breast... | irinotecan hydr... laboratory biom... | 18 Years - | University of California, Irvine | |
| Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | NCT00044785 | Solid Tumors | triacetyluridin... fluorouracil leucovorin camptosar | 18 Years - | Wellstat Therapeutics | |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF | NCT01367275 | Colorectal Canc... Colorectal Aden... | Brivanib Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
| Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan | NCT00613028 | Glioblastoma Gliosarcoma | Temo + Avastin VP-16 + Avastin | 18 Years - | Duke University | |
| Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan | NCT00613028 | Glioblastoma Gliosarcoma | Temo + Avastin VP-16 + Avastin | 18 Years - | Duke University | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center | |
| Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide | NCT00616005 | Glioblastoma | Temodar and Iri... | 18 Years - | Duke University | |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | NCT00394433 | Esophageal Canc... Stomach Cancer | Bevacizumab Docetaxel Cisplatin Irinotecan | 18 Years - | Dana-Farber Cancer Institute | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center | |
| A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) | NCT00735436 | Malignant Gliom... Glioblastoma Mu... Gliosarcoma | Gliadel/Avastin... | 18 Years - | Duke University | |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | NCT00394433 | Esophageal Canc... Stomach Cancer | Bevacizumab Docetaxel Cisplatin Irinotecan | 18 Years - | Dana-Farber Cancer Institute | |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF | NCT01367275 | Colorectal Canc... Colorectal Aden... | Brivanib Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
| Panitumumab and Irinotecan for Malignant Gliomas | NCT01017653 | Malignant Gliom... | Irinotecan Panitumumab | 18 Years - | Duke University | |
| Ph I SU011248 + Irinotecan in Treatment of Pts w MG | NCT00611728 | Glioblastoma | SU011248 & Irin... | 18 Years - | Duke University | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide | NCT00616005 | Glioblastoma | Temodar and Iri... | 18 Years - | Duke University | |
| High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma | NCT00283556 | Malignant Gliom... | Irinotecan (Cam... | 18 Years - | Kentuckiana Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
